Johnson & Johnson (JNJ) Stock Rating

Johnson & Johnson is the world's largest and most diverse healthcare company, organized into two divisions, innovative medicine and medtech, which represent all of its sales after the 2023 divestment of its consumer business, Kenvue. Following 2023-24 restructurings, its drug division focuses on immunology, oncology, and neurology, and just over half of total revenue is generated in the United States.

Rating as of 2026-07-07. Live price updates in real time.